News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Approves Warning for Carbamazepine; Shire Pharmaceuticals (SHPGY), Validus Pharmaceuticals, Inc., Novartis Corporation (NVS) Affected


12/12/2007 9:38:06 AM

WASHINGTON, Dec. 12 (UPI) -- The U.S. manufacturers of drugs containing carbamazepine have agreed to warn Asian patients to get a genetic blood test before using the medication.

Read at Elsevier
Read at PharmaLive
Read at FDA


comments powered by Disqus
Elsevier
PharmaLive
FDA
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES